Tru2u review
Flat pricing across four lines, plus a combined product that pairs both molecules for $275.
The verdict
Tru2u publishes $225 a month for semaglutide and $345 for tirzepatide, read August 2026. Orals match the injections. A combined product is $275.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $225/mo
- Oral
- From $225/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Tru2u sells both molecules by injection and as tablets. A fifth product, GLP Squared, combines the two.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. No clinician is described on the pages read.
Four of the five products are priced conventionally and flat. The fifth pairs two molecules in one purchase, which is unusual and untested.
What happens when the dose goes up?
Prices are recorded as flat across doses. No milligram appears beside any of the five products.
What the price includes
Six months of semaglutide is $1,350 and of tirzepatide is $2,070. The combined product sits between them at $275 a month, or $1,650 over six.
What it claims, and what it cites
Every line is compounded. A pharmacy prepares them to order. The FDA does not review a compounded preparation before it is dispensed, and no trial has tested the two molecules paired.
Where it holds up, and where it does not
- Strength: Flat across doses on every line
- Strength: Both formats carry a figure
- Strength: The combination is priced openly
- Limitation: The combination has no trial behind it
- Limitation: No milligram dose published anywhere
- Limitation: Nothing publishes a list of states
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Tru2u. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a flat rate and will ask what the combined product contains.
- Wrong for
- A reader treating GLP Squared as a studied treatment rather than a product.
How Tru2u compares
| Seller | Who it suits | Go |
|---|---|---|
| Luci | Readers who take an asterisk seriously and plan to ask what it hides | See Luci → |
| Rivo Health | Readers who want a flat rate and can ignore the seasonal framing | See Rivo Health → |
| Navio MD | Readers who want the branded and compounded routes priced side by side | See Navio MD → |
More GLP-1 telehealth sellers reviews: NextMedsNoBsRxNoluNovaNovoCare PharmacyNowPatient
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is GLP Squared?
- A combined semaglutide and tirzepatide product at $275 a month. No dose is published for either part.
- Do the tablets cost more?
- No. Each molecule is one figure in both formats.
- Has the combination been studied?
- No trial has tested the two molecules paired.
- Is Tru2u expensive compared with other GLP-1 telehealth sellers?
- Tru2u publishes a starting figure of $225/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Tru2u above the median. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.